Published in Medical Letter on the CDC and FDA, June 23rd, 2002
If approved, the drug, known as Alimta, would become the first medicine sanctioned by the U.S. Food and Drug Administration (FDA) specifically to treat mesothelioma. The deadly tumors of the lungs or stomach are resistant to treatment and the cancer is nearly always fatal.
Alimta could hold promise for thousands of workers in the construction and shipbuilding trades worldwide who handled asbestos and could contract mesothelioma. Lilly is seeking a priority review by the FDA, meaning the regulator would review the drug...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.